Breast cancer researchers from the Revlon/UCLA Women’s Cancer Research Program at UCLA’s Jonsson Comprehensive Cancer Center (JCCC) have concluded clinical trials on a promising now drug to combat estrogen receptor positive (ER+) breast cancer. They announced their findings on April 7 at the American Association for Cancer Research (AACR) Annual Meeting 2014, which is being…